Literature DB >> 22030827

Biochemical liver function after partial hepatic resection with or without partial hepatic vascular exclusion.

Orlando Castro e Silva1, Enio David Mente, Ajith Kumar Sankarankutty, Maria Eliza Jordani Souza, Maria Cecília Jordani Gomes, Maria Aparecida Neves Cardoso Picinato, Clarice Fleury Fina, Jorge Resende Lopes.   

Abstract

PURPOSE: The aim of the present study was to assess the advantages and disadvantages of liver vascular partial exclusion (LVPE) (liver dysfunction due to ischemia) during liver resection in patients submitted to partial hepatectomy.
METHODS: A total of 114 patients were submitted to partial hepatectomy (minor versus major resections) with LPVE being used in 57 of them but not in the remaining 57. Patient age ranged from 35 to 73 years and 57 % were women. Mitochondrial function was assessed 30 minutes after liver resection in the remnant liver and serum aminotransferases were determined before surgery and for seven days postoperatively. LPVE time ranged from 30 to 60 minutes. Data were analyzed statistically by the Student T test (5 % level of significance).
RESULTS: Mitochondrial function was similar in the minor and major liver resections. The maximum postoperative aminotransferase peak was similar in the groups with and without LPVE.
CONCLUSION: LPVE did not induce mitochondrial changes in hepatic tissue in either type of surgery, and aminotransferase levels were similar for patients with and without LPVE. Thus, the results show that LPVE is a safe procedure that does not induce the significant changes typical of ischemia and reperfusion in the liver remnant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030827     DOI: 10.1590/s0102-86502011000800022

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

Review 1.  Current role of trisectionectomy for hepatopancreatobiliary malignancies.

Authors:  Philipp Kron; Norihisa Kimura; Shahid Farid; J Peter A Lodge
Journal:  Ann Gastroenterol Surg       Date:  2019-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.